0001958244-24-002254.txt : 20240603 0001958244-24-002254.hdr.sgml : 20240603 20240603172159 ACCESSION NUMBER: 0001958244-24-002254 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240603 DATE AS OF CHANGE: 20240603 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 241015001 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Baird Melissa CENTRAL INDEX KEY: 0001837815 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 2269 CHESTNUT STREET, #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 144 1 primary_doc.xml 144 0001837815 XXXXXXXX LIVE 0001773751 Hims & Hers Health, Inc. 001-38986 2269 Chestnut Street Suite 523 San Francisco CA 94123 1-415-851-0195 Melissa Baird Officer Class A Common Goldman Sachs & Co. LLC 200 West Street New York NY 10282 70506 1444667.94 206408463 06/03/2024 NYSE Class A Common 03/29/2018 Acquired as compensation -- Stock Options The Issuer N 70506 03/29/2018 Compensation -- Cashless exercise / same-day sale N Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 05/03/2024 5036 60681.79 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 04/05/2024 5036 74027.69 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 04/08/2024 5036 74907.48 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 05/01/2024 6714 83566.47 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 05/03/2024 6714 76144.82 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 04/08/2024 6715 98346.55 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 04/04/2024 5036 75914.17 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 05/01/2024 5036 64555.48 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 05/02/2024 5036 61398.41 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 04/04/2024 6715 99018.72 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 03/06/2024 5036 70720.55 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 03/06/2024 6715 93639.33 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 04/05/2024 6715 97344.67 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 03/07/2024 6715 95985.55 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 03/05/2024 6715 95077.68 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 05/02/2024 6714 80525.03 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 03/05/2024 5036 71984.58 Melissa Baird 10b5-1 Brokerage 2269 Chestnut Street Suite 523 San Francisco CA 94123 Class A Common 03/07/2024 5036 72698.69 The sales of shares set forth herein are made in connection with a selling plan dated 11/21/2023, that is intended to comply with Rule 10b5-1(c). 06/03/2024 11/21/2023 Goldman Sachs & Co. LLC on behalf of Melissa Baird